111, Inc. Sponsored ADR (NASDAQ:YI) Short Interest Down 45.1% in April

111, Inc. Sponsored ADR (NASDAQ:YI) was the target of a large drop in short interest in the month of April. As of April 30th, there was short interest totaling 13,805 shares, a drop of 45.1% from the April 15th total of 25,129 shares. Based on an average daily volume of 11,742 shares, the days-to-cover ratio is currently 1.2 days. Currently, 0.3% of the company’s shares are sold short.

111 Stock Down 3.5%

Shares of YI traded down $0.21 during midday trading on Friday, reaching $5.79. 8,991 shares of the stock were exchanged, compared to its average volume of 12,981. The firm has a 50 day simple moving average of $6.50 and a 200-day simple moving average of $5.49. 111 has a 12-month low of $2.48 and a 12-month high of $11.17. The company has a market cap of $50.87 million, a price-to-earnings ratio of -5.79 and a beta of 0.66.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings lowered 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, May 7th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, 111 presently has an average rating of “Sell”.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.